Subsequently, we induced hypospadias in rats by gestational exposure using the prostate cancer drug and potent AR antagonist flutamide as model chemical, with the aim to investigate how anti-androgenic EDCs may impact penis development by affecting both AR and ER signaling. This evidence concerns the gene AR and hypospadias.